Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,408,715,236
+$220,410,125 QoQ
Shares Held
3,890,189
+15.2% QoQ
Ownership
0.720%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#20
of 3,131 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Amundi holds $20,539,050,875 across 14 Drug Manufacturers - General names. AMGN ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,808,143 | $5,767,031,432 | |
| 2 | JNJ |
Johnson & Johnson
|
13,117,657 | $3,331,491,343 | |
| 3 | AZN |
Astrazeneca PLC
|
16,422,784 | $3,114,088,296 | |
| 4 | ABBV |
AbbVie Inc.
|
10,039,289 | $2,526,286,678 | |
| 5 | MRK |
Merck & Co., Inc.
|
12,342,274 | $1,585,982,207 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,890,189 | $1,408,715,236 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,772,438 | $1,234,649,812 | |
| 8 | PFE |
Pfizer Inc
|
33,533,616 | $807,489,467 |
All Filings in AMGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,408,715,236 | 3,890,189 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $1,188,305,111 | 3,377,306 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $1,111,854,064 | 3,396,945 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $679,562,712 | 2,408,089 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $643,067,813 | 2,303,169 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $600,338,459 | 1,926,941 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $678,185,272 | 2,602,000 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $953,490,265 | 2,959,220 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,044,166,644 | 3,341,868 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $957,706,322 | 3,368,410 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $872,376,281 | 3,028,874 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $794,767,655 | 2,957,165 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $614,036,268 | 2,765,680 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $555,306,271 | 2,297,027 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $768,577,345 | 2,926,353 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $553,941,006 | 2,457,591 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $406,944,547 | 1,672,604 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $451,851,059 | 1,868,543 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $397,424,793 | 1,766,568 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $293,664,331 | 1,380,975 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $402,404,429 | 1,650,890 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||